2
Agriculture • Biotechnology • Blueberries and other fruits • Cotton • Forages • Ornamental plants • Peanuts • Plant pest detection and protection • Small grains • Soybeans • Turfgrass Biofuels, Biomass Utilization, Renewable Energy • Algal biofuels • Biodiesel • Biomass engineering • Biomass pre-treatment • Chemicals from sugar mixtures • Delignification • Enzymes and clones • Hydrogen generation • Polysaccharides quantification and characterization Commodity Chemicals • Chiral amino acid derivatives • Diols • Production of succinate, pyruvate and proteins from fermentations Food Quality and Safety • Competitive exclusion • Food decontamination • Pathogen detection • Probiotics Homeland Security • Antimicrobials for use in the food supply and consumption chain • Diagnostic, prophylactic and therapeutic measures against anthrax and B. cereus • Rapid identification of pathogens (e.g., Y. pestis, Anthracis, B. cereus, avian flu viruses) • Remediation of contamination by munitions Human Health • Antimicrobials • Antivirals • Biomarkers • Cardiovascular health • Cognitive disorders • Diagnostics • Inflammation • Obesity and weight loss • Ophthalmic care • Oral health care • Stem cells (regenerative medicine and diagnostic uses) • Tissue repair, skin care, and wound healing • Vaccines Information Technology • Bioinformatics tools • Image rendering and enhancement • 3D imaging and medical simulation Research Tools • Carbohydrates analysis • HTP protein expression and gene silencing • Monoclonal and polyclonal antibodies • Peptides, proteins • Vectors and plasmids Socially Responsible / Humanitarian Licensing • Assistive technologies • Diagnostics and therapeutics for Chagas disease, African Sleeping Sickness • Educational tools • Food crops Veterinary • Animal nutrition • Poultry vaccines • Probiotics • Wound healing Technologies with Global Impact University of Georgia Research Foundation, Inc. Technology Commercialization Office is among the best university technology transfer programs in the country. * We offer a one-stop solution for ease of collaboration and industry-friendly experience for companies seeking access to technologies. For more information, contact: Technology Commercialization Office 808 Boyd GSRC 200 D.W. Brooks Drive Athens, GA 30602-7411 USA phone +1 (706) 542-1404 fax +1 (706) 542-3837 [email protected] www.ovpr.uga.edu/tco/ For additional information, please visit www.ovpr.uga.edu/tco/ * Association of University Technology Managers (AUTM) Technology Commercialization Office From Idea to Marketplace INNOVATIVE SOLUTIONS TO GLOBAL NEEDS www.ovpr.uga.edu/tco/ 2 ND IN THE U.S. for licenses 4 consecutive years 300 PRODUCTS in the marketplace OVER

Technology Commercialization Office INNOVATIVE SOLUTIONSresearch.uga.edu/docs/units/tco/Innovative-Solutions... · 2020. 8. 8. · • Carbohydrates analysis • HTP protein expression

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Technology Commercialization Office INNOVATIVE SOLUTIONSresearch.uga.edu/docs/units/tco/Innovative-Solutions... · 2020. 8. 8. · • Carbohydrates analysis • HTP protein expression

Agriculture •Biotechnology

•Blueberriesandotherfruits

•Cotton

•Forages

•Ornamentalplants

•Peanuts

•Plantpestdetectionandprotection

•Smallgrains

•Soybeans

•Turfgrass

Biofuels, Biomass Utilization, Renewable Energy •Algalbiofuels

•Biodiesel

•Biomassengineering

•Biomasspre-treatment

•Chemicalsfromsugarmixtures

•Delignification

•Enzymesandclones

•Hydrogengeneration

•Polysaccharidesquantification

andcharacterization

Commodity Chemicals •Chiralaminoacidderivatives

•Diols

•Productionofsuccinate,pyruvateand

proteinsfromfermentations

Food Quality and Safety •Competitiveexclusion

•Fooddecontamination

•Pathogendetection

•Probiotics

Homeland Security •Antimicrobialsforuseinthefoodsupplyandconsumptionchain

•Diagnostic,prophylacticandtherapeuticmeasuresagainst

anthraxandB. cereus

•Rapididentificationofpathogens(e.g.,Y. pestis,Anthracis,

B. cereus,avianfluviruses)

•Remediationofcontaminationbymunitions

Human Health •Antimicrobials

•Antivirals

•Biomarkers

•Cardiovascularhealth

•Cognitivedisorders

•Diagnostics

•Inflammation

•Obesityandweightloss

•Ophthalmiccare

•Oralhealthcare

•Stemcells(regenerativemedicineanddiagnosticuses)

•Tissuerepair,skincare,andwoundhealing

•Vaccines

Information Technology •Bioinformaticstools

•Imagerenderingandenhancement

•3Dimagingandmedicalsimulation

Research Tools •Carbohydratesanalysis

•HTPproteinexpressionandgenesilencing

•Monoclonalandpolyclonalantibodies

•Peptides,proteins

•Vectorsandplasmids

Socially Responsible / Humanitarian Licensing •Assistivetechnologies

•Diagnosticsandtherapeuticsfor

Chagasdisease,AfricanSleepingSickness

•Educationaltools

•Foodcrops

Veterinary •Animalnutrition

•Poultryvaccines

•Probiotics

•Woundhealing

TechnologieswithGlobalImpact

University of Georgia Research Foundation, Inc. Technology Commercialization Office

isamongthebestuniversitytechnology

transferprogramsinthecountry.*

Weofferaone-stopsolutionforeaseofcollaboration

andindustry-friendlyexperienceforcompaniesseeking

accesstotechnologies.Formoreinformation,contact:

Technology Commercialization Office808BoydGSRC

200D.W.BrooksDrive

Athens,GA30602-7411

USA

phone+1(706)542-1404fax+1(706)542-3837

[email protected]

www.ovpr.uga.edu/tco/

Foradditionalinformation,pleasevisitwww.ovpr.uga.edu/tco/ *Association of University Technology Managers (AUTM)

Technology Commercialization Office

From Idea to Marketplace

INNOVATIVESOLUTIONSTOGLOBALNEEDS

www.ovpr.uga.edu/tco/

2NDIN THE U.S.

for licenses4 consecutive years

300PRODUCTS

in themarketplace

OVER

Page 2: Technology Commercialization Office INNOVATIVE SOLUTIONSresearch.uga.edu/docs/units/tco/Innovative-Solutions... · 2020. 8. 8. · • Carbohydrates analysis • HTP protein expression

The Technology Commercialization Office (TCO) servestheUniversityofGeorgiacommunitybyconnectingindustrywithuniversityexpertiseandinventionsforthepublicgood,promotingeconomicdevelopment,andincreasingresearchvisibility.

The University of Georgia Research Foundation, Inc. (UGARF)administersallintellectualpropertydevelopedattheUniversityofGeorgia(UGA).UGARFenhancesUGA’sresearchexcellenceby:

Securingresearchandeducationcontractsandgrants fromindustry,governmentagencies,publicand privateorganizations.

Protectingandtransferringtechnologytotheprivate sector,generatingincomethatfurthersupportsthe UGAresearchenterprise.

Investing in the Research PipelineRevenuefromUGARF’slicensingprogramissharedwiththeinventors,usedtofundadditionalresearch,andinvestedinnewequipmentandresearchfacilities.

Supporting Economic DevelopmentUGARF’snewtechnologiesarelicensedtothecommercialsector,leadingtonewproductsandservicesofferedthroughouttheworld.InnovationsbyUniversityofGeorgiaresearchersboosttheeconomiesofourstateandcountry,andhelpcreatenewbusinesses,industriesandmarketsaddressingunmetglobalneeds.

Socially Responsible/Humanitarian LicensingOurlicensingprogramconnectsuniversitydiscoveriestopopulationsinneedthroughouttheworld.Areasoftechnologyincludeneglecteddiseases,supportingpersonswithdisabilities,andeducationaltools.

Support for UGA Researchers and PartnersInadditiontolicensing,TCOalsoprovidessupportservicestoUGAresearchersandcollaborateswithcorporatepartnersinavarietyofways.Ourstaffassistwith:

• Materialtransferagreements • Confidentialityagreements • Inter-institutionalagreements • Inventiondisclosureassessmentandprotection • Collaborativeresearchagreements • Evaluationandtestingagreements

Ourresearchersareconstantlyseekingsolutionstoglobalproblemsandstrivingtoimprovethequalityoflifeforhumankind.

Fromnew vaccinesthatprotectanimalandhumanhealthtotherapeuticsanddiagnosticsfordevastatingdiseases,

Frommorecost-effective,environmentally friendly fuelstonewwaystoensure a safe food supply,and

Frombeautifulflowering plantstonew cropsthatfeedtheworld,

Technologies fromtheUniversityofGeorgia benefit the global community.

University of Georgia Research Foundation licensesinnovative technologies to address global needs.

Georgia

LicensingRevenue

InventionDisclosures

Licenses/Options

5-Year Totals

2007-2011